Passive anti-amyloid β immunotherapy in Alzheimer's disease—opportunities and challenges
Michael Thomas Heneka, David Morgan, Frank Jessen
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1016/s0140-6736(24)01883-x
- Published
- Nov 1, 2024
- Venue
- The Lancet
- DOI
- 10.1016/s0140-6736(24)01883-x
- PubMed
- 39549715
- Categories
- Alzheimer's disease research and treatments
- Provenance
- openalex